NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Liyu Daily? Mail in a sample (US only) and let us test it.

Test my supply
78%
Finnrick rating
#144 of 500 ranked vendors
8 of 10 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Liyu Daily's Purity focus record is strongest on Tirzepatide, where the available tests all clear identity, purity, and fill checks. Retatrutide is more dispersed, with identity holding but a severe underfill and one low-purity result before later passes; evidence is recent but limited to two peptides.

methodology →
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Jun 2026: 75%13 Jul 2026: 78%13 Jul 2026: 78%12 Aug 2026: 79%16 Sep 2026: 77%18 Sep 2026: 77%18 Sep 2026: 77%24 Sep 2026: 78%24 Sep 2026: 78%13 Oct 2026: 79%17 Nov 2026: current 78%75%77%78%Jun 26Nov 26
Liyu Daily test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
13 Oct 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
Tirzepatide
lab nameView COA
18 Sep 2026
Pass
Tirzepatide
lab nameView COA
18 Sep 2026
Pass
Retatrutide
lab nameView COA
16 Sep 2026
Fail
Retatrutide
lab nameView COA
12 Aug 2026
Pass
Retatrutide
lab nameView COA
13 Jul 2026
Pass
Tirzepatide
lab nameView COA
13 Jul 2026
Pass
Retatrutide
lab nameView COA
24 Jun 2026
Fail
Retatrutide
lab nameView COA

About Liyu Daily test results from Finnrick

Liyu Daily is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 10 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Liyu Daily peptides in this dataset are Retatrutide (7 tests), Tirzepatide (3 tests) and BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 10 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Liyu Daily? Mail in a sample (US only) and let us test it.

Test my supply